Patient selection and electroconvulsive therapy indications

Electroconvulsive and Neuromodulation Therapies

Volumn , Issue , 2009, Pages 341-361

  Swartz, Conrad M ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951782671     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511576393.023     Document Type: Chapter

References (60)

1. American Psychiatric Association. 2001. The practice of ECT: Recommendations for treatment, training, and privileging, 2nd edn.Washington DC: American Psychiatric Press.
2. Andreescu, C., Lenze, E. J., Dew, M. A., et al. 2007. Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: Controlled study. Br J Psychiatry 190: 344-9.
3. Aronson, T. A., Shukla, S., Hoff, A., and Cook, B. 1988. Proposed delusional depression subtypes: Preliminary evidence from a retrospective study of phenomenology and treatment course. J Affect Disord 14: 69-74.
4. Avery, D. and Lubrano, A. 1979. Depression treated with imipramine and ECT: The DeCarolis study reconsidered. Am J Psychiatry 136: 559-62.
5. Beekman, A. T., de Beurs, E., van Balkom, A. J., et al. 2000. Anxiety and depression in later life: Co-occurrence and communality of risk factors. Am J Psychiatry 157: 89-95.
6. Brown, R. P., Frances, A., Kocsis, J. H., andMann, J. J. 1982. Psychotic vs. nonpsychotic depression: Comparison of treatment response. J Nerv Ment Dis 170: 635-7.
7. Chelminski, I., Zimmerman, M., andMattia, J. I. 2000. Diagnosing melancholia. JClin Psychiatry 61: 874-5.
8. Ciapparelli, A., Paggini, R., Marazziti, D., et al. 2007. Comorbidity with axis I anxiety disorders in remitted psychotic patients 1 year after hospitalization. CNS Spectr 12: 913-19.
9. Cole, M. 2008, January 17. Feds slam state hospital safety. The Oregonian (Portland newspaper) p. 1.
10. Crebbin, K., Mitford, E., Paxton, R., and Turkington, D. 2008. First-episode psychosis: An epidemiological survey comparing psychotic depression with schizophrenia. J Affect Disord 105: 117-24.
11. Davidson, J., McLeod, M., Law-Yone, B., and Linnoila, M. 1978. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. Arch Gen Psychiatry 35: 639-42.
12. Frueh, B. C., Knapp, R. G., Cusack, K. J., et al. 2005. Patients' reports of traumatic or harmful experience within the psychiatric setting. Psychiatr Serv 56: 1123-33.
13. Gimsa, U., Schreiber, U., Habel, B., et al. 2006. Matching geometry and stimulation parameters of electrodes for deep brain stimulation experiments - numerical considerations. J Neurosci Meth 150: 212-27.
14. Glassman, A. H., Kantor, S. J., and Shostak, M. 1975. Depression, delusions, and drug response. Am J Psychiatry 132: 716-19.
15. Hamilton, M. 1989. Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry 154: 201-6.
16. Hatta, K., Miyakawa, K., Ota, T., et al. 2007. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. J ECT 23: 233-5.
17. Husain, M. M., McClintock, S. M., Rush, A. J., et al. 2008. The efficacy of acute electroconvulsive therapy in atypical depression. J Clin Psychiatry 69: 406-11.
18. Jansen, A. S. P., Nguyen, X. V., Karpitskiy, V., et al. 1995. Central command neurons of the sympathetic nervous system: Basis of the fight-or-flight response. Science 270: 644-6.
19. Jarrett, R. B., Schaffer, M., McIntire, D., et al. 2000. Treatment of atypical depression with cognitive therapy or phenelzine:Adouble-blind, placebo-controlled trial.Arch Gen Psychiatry 56: 431-7.
20. Kantor, S. J. and Glassman, A. H. 1977. Delusional depressions: Natural history and response to treatment. Br J Psychiatry 131: 351-60.
21. Kellner, C. H., Fink, M., Knapp, R., et al. 2005. Relief of expressed suicidal intent by ECT: A consortium for research in ECT study. Am J Psychiatry 162: 977-82.
22. Khanna, S., Gangadhar, B. N., Sinha, V., et al. 1988. ECT in obsessive-compulsive disorder. Convuls Ther 4: 314-20.
23. La Rue, A., Spar, J., and Hill, C. D. 1986. Cognitive impairment in late-life depression: Clinical correlates and treatment implications. J Affect Disord 11: 179-84.
24. Lesser, I., Castro, D., Gaynes, B., et al. 2007. Ethnicity/race and outcome in the treatment of depression: Results from STAR∗D. Med Care 45: 1043-51.
25. Lewis, D. A. and Smith, R. E. 1983. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 5: 319-32.
26. Lu, M. L., Pan, J. J., Teng, H.W., et al. 2002. Metoclopramide-induced supersensitivity psychosis. Ann Pharmacother 36(9): 1387-90.
27. Lykouras, E., Malliaras, D., Christodoulou, G. N., et al. 1986a. Delusional depression: Phenomenology and response to treatment. Psychopathology 19: 157-64.
28. Lykouras, E., Malliaras, D., Christodoulou, G. N., et al. 1986b. Delusional depression: Phenomenology and response to treatment. A prospective study. Acta Psychiatr Scand 73: 324-9.
29. Maj, M., Pirozzi, R., Formicola, A. M., et al. 2000. Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: Preliminary data. J Affect Disord 57: 95-8.
30. Maletzky, B., McFarland, B., and Burt, A. 1994. Refractory obsessive compulsive disorder and ECT. Convuls Ther 10: 34-42.
31. Markowitz, J., Brown, R., Sweeney, J., and Mann, J. J. 1987. Reduced length and cost of hospital stay for major depression in patients treated with ECT. Am J Psychiatry 144: 1025-9.
32. Minter, R. E. and Mandel, M. R. 1979. The treatment of psychotic major depressive disorder with drugs and electroconvulsive therapy. J Nerv Ment Dis 167: 726-33.
33. Mulsant, B. H., Haskett, R. F., Prudic, J., et al. 1997. Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry 154: 559-61.
34. Nelson, J. C. and Charney, D. S. 1981. The symptoms ofmajor depressive illness. AmJ Psychiatry 138: 1-13.
35. Nelson, J.C., Price, L. H., and Jatlow, P. I. 1986. Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression. Am J Psychiatry 143: 1151-4.
36. Nelson, L. A. and Swartz, C. M. 2000. Melancholic symptoms from concurrent olanzapine and fluoxetine. Ann Clin Psychiatry 12: 167-70.
37. Nimgaonkar, V. L., Goodwin, G. M., Davies, C. L., and Green, A. R. 1985. Down-regulation of beta-adrenoceptors in rat cortex by repeated administration of desipramine, electroconvulsive shock and clenbuterol requires 5-HT neurones but not 5-HT.Neuropharmacology 24: 279-83.
38. Nobler, M. S. and Roose, S. P. 1998. Differential response to antidepressants in melancholic and severe depression. Psychiatr Ann 28: 84-8.
39. Ottosson, J. O. 1960. Effect of lidocaine on the seizure discharge in electroconvulsive therapy. Acta Psychiatr Scand Suppl 35(145): 7-32.
40. Parker, G., Hadzi-Pavlovic, D., Austin, M. P., et al. 1995. Is psychomotor disturbance necessary and sufficient to the definition of melancholia? Psychol Med 25: 813-23.
41. Parker, G., Hadzi-Pavlovic, D., Hickie, I., et al. 1991. Psychotic depression: A review and clinical experience. Aust N Z J Psychiatry 25: 169-80.
42. Parker, G., Roy, K., Hadzi-Pavlovic, D., and Pedic, F. 1992. Psychotic (delusional) depression: A meta-analysis of physical treatments. J Affect Disord 24: 17-24.
43. Parker, G., Roy, K., Mitchell, P., et al. 2002. Atypical depression: A reappraisal. Am J Psychiatry 159: 1470-9.
44. Perry, P. J., Morgan, D. E., Smith, R. E., and Tsuang, M. T. 1982. Treatment of unipolar depression accompanied by delusions. ECT versus tricyclic antidepressant - antipsychotic combinations. J Affect Disord 4: 195-200.
45. Pluijms, E. M., Birkenhager, T. K., Huijbrechts, I. P., andMoleman, P. 2002. Influence of resistance to antidepressant pharmacotherapy on short-term response to electroconvulsive therapy. J Affect Disord 69: 93-9.
46. Prudic, J., Haskett, R. F., Mulsant, B., et al. 1996. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 153: 985-92.
47. Prudic, J., Olfson, M., Marcus, S. C., et al. 2005. Effectiveness of ECT in community settings. Biol Psychiatry 55: 301-12.
48. Prudic, J., Sackeim, H., and Devanand, D. 1990. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 31: 287-96.
49. Roose, S. P., Glassman, A. H., Attia, E., andWoodring, S. 1994. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 151: 1735-9.
50. Sackeim, H. A., Prudic, J., Devanand, D. P., et al. 2000. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57: 425-34.
51. Sernyak, M. J., Griffin, R. A., Johnson, R. M., et al. 1994. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 151: 133-5.
52. Swartz, C. M. 1998. Betaxolol in anxiety disorders. Ann Clin Psychiatry 10: 9-14.
53. Swartz, C. M. 2002a. Olanzapine-induced depression. J Pharm Technol 18: 321-3.
54. Swartz, C. M. 2002b, September 19. PTSD from psychiatric illness. Psychiatric Times 9: 18-20.
55. Swartz, C. M. 2003, April 20. Evidence versus subjectivity in major depression. Psychiatric Times 4: 30-2.
56. Swartz, C. M. 2004, October 21. Antipsychotic psychosis. Psychiatric Times 11: 17-20.
57. Swartz, C. M. and Inglis, A. E. 1990. Blood pressure fall with ECT response in males: Evidence for depression-induced hypertension. J Clin Psychiatry 51: 414-16.
58. Swartz, C.M. and Shorter E. 2007. Psychotic depression. New York: Cambridge University Press.
59. Turner, E. H., Matthews, A. M., Linardatos, E., et al. 2008. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358: 252-60.
60. Zimmerman, M., Chelminski, I., and McDermut, W. 2002. Major depressive disorder and axis I diagnostic comorbidity. J Clin Psychiatry 63: 187-93.